| NexLife | Form Health | |
|---|---|---|
| Model | Cash-pay compounded tirzepatide and semaglutide | Insurance-billed obesity medicine program; FDA-approved medication "if appropriate" |
| Price | Tirzepatide $129, $125, $119, $115; semaglutide $109, $105, $99, $95 (month to month, 3, 6, 12 months) | None printed; /pricing redirected to the homepage |
| Billing basis | Per month, same price at every dose | Through your insurance |
| Membership | None | A "Cancel Membership" link; no fee printed |
| Included | Medication, provider review, nutrition plan, coaching call, 24/7 support, shipping | Physician-led team: obesity medicine clinician, endocrinologists, registered dietitians, advanced practice providers |
| Pharmacy disclosure | Three named 503A pharmacies | Not applicable to compounding; none named |
| Medical group named | NexLife Medical Group; medical director Adam Kennah, M.D. | Form Health Associates P.C. entities and Healthy Life Physicians Group entities |
| Cancellation | Takes effect after 30 days; shipped orders final | No terms in the homepage text |
| FDA status of medication | Compounded: not FDA-approved | FDA-approved medications |
Insurance-based care vs cash-pay compounding: which question comes first?
Your coverage. Form Health is built for people whose insurance pays for obesity care, and its homepage says it is "covered by national health insurance plans, including Medicare." NexLife is built for people paying cash, and it prints every price. If your plan covers specialist visits and a GLP-1, Form Health could cost you less and get you an FDA-approved drug. If it does not, NexLife's printed $1,380 a year is a known number and Form Health's cost is not.
The Medicare case
This is where an insurance-billed program can clearly win. The Medicare GLP-1 Bridge, running from July 1, 2026 to December 31, 2027, sets a $50 copay for eligible Part D enrollees on Foundayo, Wegovy or the Zepbound KwikPen (not vials). Eligibility per Medicare.gov is a BMI of 35 or more, or 30 or more or 27 or more with listed conditions. Medicare does not pay for compounded drugs, so NexLife would be cash pay for a Medicare member.
| Route | Medication for 12 months | What it buys |
|---|---|---|
| Bridge-covered brand drug at a $50 copay | 12 × $50 = $600 | FDA-approved Wegovy, Foundayo or Zepbound KwikPen |
| NexLife compounded tirzepatide, 12-month plan | $1,380 (care included) | Compounded, not FDA-approved |
| NexLife compounded semaglutide, 12-month plan | $1,140 (care included) | Compounded, not FDA-approved |
Two cautions. The Form Health column leaves out whatever you would pay for visits, which Form Health does not print. And Form Health's homepage did not say whether it prescribes under the Bridge, only that Medicare covers its services. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge; their Part D plan might cover a GLP-1 under its normal rules. Our Medicare Part D guide explains the details.
What about commercial insurance?
It depends on your plan's rules, which neither program controls. Many employer plans cover visits with an obesity medicine specialist but exclude weight-loss drugs, or cover them only after prior authorization. If your plan covers both the visits and a drug such as Wegovy or Zepbound, Form Health's route could cost you only copays and an FDA-approved product. If your plan covers the visits but not the drug, you could end up paying Form Health visit copays plus a brand self-pay price, which would cost more than NexLife's all-in plan. Call your insurer with three questions: is Form Health in network, is a GLP-1 covered for weight management, and what is the copay for each.
If you have no coverage
Then NexLife is the program you can price. Without insurance, Form Health would need to quote you visit and membership fees directly, and your medication would cost the manufacturer's self-pay price, such as NovoCare's $349 for the Wegovy pen (read November 8, 2026), or 12 × $349 = $4,188 a year as arithmetic. NexLife's $1,380 tirzepatide or $1,140 semaglutide plan includes the clinical service. The trade is product for price: brand and FDA-approved at Form Health, compounded and not FDA-approved at NexLife.
What could we not compare?
Form Health's visit costs, membership fee, in-network insurers and cancellation terms, none of which appear on its site. On NexLife's side, whether a multi-month plan will be charged upfront (its FAQ) or monthly (its cancellation policy). Neither program lists lab work as included.
Pick Form Health when
- You are on Medicare Part D and meet the Bridge criteria, or your commercial plan covers obesity care and a GLP-1.
- You want a multidisciplinary team with dietitians and endocrinologists, not just a prescription.
- You want FDA-approved medication only, and are open to a plan that may not include a GLP-1 at all.
Pick NexLife when
- You are paying cash and want to know the full yearly cost before you start.
- You want compounded tirzepatide or semaglutide at one price for every dose.
- You want named pharmacies and written cancellation terms up front.
Summary
These programs serve different people. Form Health makes sense when insurance or Medicare carries the cost and you want a full medical team; NexLife makes sense when you are paying yourself and want printed, all-in prices. NexLife is our editorial pick; on our computed transparency index it meets 5 of 6 checks and Form Health 1 of 5. Read the Form Health review, the NexLife review and our insurance coverage guide.
Frequently asked questions
Is Form Health cheaper than NexLife?
It can be, if insurance pays. Form Health printed no prices on October 15 or November 8, 2026, and bills insurance, including Medicare. For an eligible Medicare Part D enrollee, the GLP-1 Bridge copay of $50 comes to $600 for 12 fills as arithmetic, before any visit costs. NexLife's 12-month compounded tirzepatide plan is $1,380 cash as of November 6, 2026.
Does Form Health take Medicare?
Form Health's homepage, read November 8, 2026, says it is covered by national health insurance plans, including Medicare. It did not say whether it prescribes under the Medicare GLP-1 Bridge, which covers Foundayo, Wegovy and the Zepbound KwikPen for eligible Part D enrollees from July 1, 2026 to December 31, 2027. Ask Form Health directly.
Can Medicare pay for NexLife?
No. NexLife prescribes compounded tirzepatide and semaglutide, which are not FDA-approved, and the Medicare GLP-1 Bridge covers only Foundayo, Wegovy and the Zepbound KwikPen. A Medicare member using NexLife would pay its cash prices, such as $129 a month for tirzepatide month to month as of November 6, 2026. NexLife's plan pages say FSA and HSA cards are accepted.
Which program prescribes FDA-approved medication?
Form Health. Its homepage lists "FDA-approved medication, if appropriate" as part of a plan that also covers nutrition, behavioral health and physical activity. NexLife prescribes compounded tirzepatide and semaglutide, which are made with the drug in Zepbound or Wegovy but are not the same product and are not FDA-approved.
What if I have no insurance?
Without coverage, Form Health printed no self-pay rates, so you would need a quote for visits plus the manufacturer's price for any brand drug, such as NovoCare's $349 for the Wegovy pen, read November 8, 2026. NexLife's printed prices include care: $1,380 for a 12-month tirzepatide plan or $1,140 for semaglutide as of November 6, 2026.
Sources
- NexLife: tirzepatide plans — prices as of 2026-11-06; pharmacies, medical director and cancellation wording read 2026-10-15
- NexLife: semaglutide plans — prices as of 2026-11-06
- Form Health: homepage — no prices noted 2026-10-15; insurance, care-team and medical-group wording read 2026-11-08
- Medicare.gov: Weight-loss drug coverage (GLP-1 Bridge) — $50 copay, covered drugs, eligibility and exclusions read 2026-11-08
- NovoCare: Wegovy savings offer and self-pay prices — pen self-pay price read 2026-11-08
Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.
Check NexLife's plans and state availability → See the price index